Global Medical Device Podcast powered by Greenlight Guru
Un podcast de Greenlight Guru + Medical Device Entrepreneurs - Les lundis
416 Épisodes
-
Bridging the Gap between Medical Devices and Clinical Data
Publié: 20/04/2022 -
Navigating the Medical Device Single Audit Program (MDSAP)
Publié: 13/04/2022 -
Bringing Augmented Reality MedTech to Market
Publié: 07/04/2022 -
Making Your Informational Meetings with FDA Valuable & Worthwhile
Publié: 30/03/2022 -
Building Your Bill of Materials (BOM) to Accommodate Crossfunctional Needs
Publié: 23/03/2022 -
QMSR: The Future of FDA's Quality Management System Regulation for Medical Devices
Publié: 16/03/2022 -
How Medical Device Intellectual Property Protection Varies by Sector
Publié: 09/03/2022 -
Human Factors & Risk Management: What's Needed & Why?
Publié: 02/03/2022 -
What are the Opportunities for Improvement (OFI) for Quality?
Publié: 23/02/2022 -
Overcoming Barriers to Receiving 510(k) Clearance: One Company's Go-to-Market Triumph
Publié: 17/02/2022 -
How to Select a Contract Manufacturer
Publié: 02/02/2022 -
A Regulatory Gap Analysis of FDA's Systems & Policies
Publié: 26/01/2022 -
Greenlight Guru Acquires CanvasGT: A Fire(less)side Chat
Publié: 19/01/2022 -
Tips for Being Prepared Post-EUA (Emergency Use Authorization)
Publié: 12/01/2022 -
Understanding the UDI System for Medical Devices
Publié: 06/01/2022 -
Shaking Things Up: What's Next for the Global Medical Device Podcast
Publié: 16/12/2021 -
How Augmented Reality (AR) is Revolutionizing Healthcare
Publié: 09/12/2021 -
Why FDA is Prioritizing Clinical Decision Support Software & Why You Should Care
Publié: 02/12/2021 -
Why Usability Matters
Publié: 24/11/2021 -
A Special Glimpse into Medtronic's Recent Developments in Spine & Biologics Technology
Publié: 17/11/2021
The Global Medical Device Podcast, powered by Greenlight Guru, is where today's brightest minds in the medical device industry go to get their most useful and actionable insider knowledge, direct from some of the world's leading medical device experts and companies.
